Ikarian Capital’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $176K | Sell |
35,300
-164,700
| -82% | -$822K | 0.03% | 86 |
|
|
2025
Q1 | $1.6M | Sell |
200,000
-770,259
| -79% | -$6.17M | 0.2% | 49 |
|
|
2024
Q4 | $7.21M | Sell |
970,259
-100
| -0% | -$743 | 0.98% | 13 |
|
|
2024
Q3 | $9.22M | Buy |
970,359
+915,629
| +1,673% | +$8.7M | 1.29% | 9 |
|
|
2024
Q2 | $682K | Buy |
54,730
+8,082
| +17% | +$101K | 0.12% | 62 |
|
|
2024
Q1 | $1.01M | Buy |
+46,648
| New | +$1.01M | 0.11% | 57 |
|
|
2022
Q2 | – | Sell |
-265
| Closed | -$554K | – | 107 |
|
|
2022
Q1 | $554K | Buy |
265
+15
| +6% | +$31.4K | 0.07% | 92 |
|
|
2021
Q4 | $1.22M | Hold |
250
| – | – | 0.18% | 61 |
|
|
2021
Q3 | $1.57M | Sell |
250
-62
| -20% | -$388K | 0.11% | 79 |
|
|
2021
Q2 | $2.93M | Hold |
312
| – | – | 0.24% | 57 |
|
|
2021
Q1 | $2.71M | Buy |
312
+242
| +346% | +$2.1M | 0.09% | 86 |
|
|
2020
Q4 | $536K | Hold |
70
| – | – | 0.02% | 101 |
|
|
2020
Q3 | $460K | Sell |
70
-70
| -50% | -$460K | 0.03% | 82 |
|
|
2020
Q2 | $1.05M | Sell |
140
-56
| -29% | -$419K | 0.08% | 51 |
|
|
2020
Q1 | $1.4M | Buy |
196
+16
| +9% | +$114K | 0.11% | 42 |
|
|
2019
Q4 | $2.8M | Buy |
+180
| New | +$2.8M | 0.45% | 15 |
|